Literature DB >> 35601911

Safety and Efficacy of Cell Transplantation on Improving Motor Symptoms in Patients With Parkinson's Disease: A Meta-Analysis.

Jiaming Wang1, Yu Tian1, Xin Shi2, Zhaohai Feng1, Lei Jiang1, Yujun Hao1.   

Abstract

Background: The past four decades have seen the growing use of tissue or cell transplants in Parkinson's disease (PD) treatment. Parkinson's cell therapy is a promising new treatment; however, efficacy of cell transplantation for Parkinson's disease are entirely unclear. Objective: To conduct a meta-analysis and a systematic review of the efficacy of cell therapy in patients with PD.
Methods: A systematic literature review and meta-analysis of 10 studies were performed to assess the efficacy of cell therapy in Parkinson's patients. To achieve this, we compared the change in Unified Parkinson's Disease Rating Scale (UPDRS) II and III scale scores to baseline and assessed the incidence of transplant-related adverse events. The MINORS score and the I2 index were applied to evaluate the quality of studies between-study heterogeneity, respectively.
Results: The literature search yielded 10 articles (n = 120). The improvement in motor function based on the UPDRSIII assessment was -14.044 (95% CI: -20.761, -7.327) (p < 0.001), whereas improvement in daily living ability based on the UPDRSII assessment was -5.661 (95% CI: -7.632, -3.689) (p < 0.001).
Conclusion: The present findings demonstrate important clues on the therapeutic effect of cell therapy in alleviating motor impairment and daily living ability in PD patients.
Copyright © 2022 Wang, Tian, Shi, Feng, Jiang and Hao.

Entities:  

Keywords:  Parkinson’s disease; cell transplantation; meta-analysis; motor; stem cells

Year:  2022        PMID: 35601911      PMCID: PMC9120834          DOI: 10.3389/fnhum.2022.849069

Source DB:  PubMed          Journal:  Front Hum Neurosci        ISSN: 1662-5161            Impact factor:   3.169


  47 in total

1.  Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease.

Authors:  Jeffrey H Kordower; Yaping Chu; Robert A Hauser; Thomas B Freeman; C Warren Olanow
Journal:  Nat Med       Date:  2008-04-06       Impact factor: 53.440

2.  Transplantation of Neural Precursor Cells in the Treatment of Parkinson Disease: An Efficacy and Safety Analysis.

Authors:  Leng Lige; Tian Zengmin
Journal:  Turk Neurosurg       Date:  2016       Impact factor: 1.003

3.  Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study.

Authors:  Raul Martínez-Fernández; Rafael Rodríguez-Rojas; Marta Del Álamo; Frida Hernández-Fernández; Jose A Pineda-Pardo; Michele Dileone; Fernando Alonso-Frech; Guglielmo Foffani; Ignacio Obeso; Carmen Gasca-Salas; Esther de Luis-Pastor; Lydia Vela; José A Obeso
Journal:  Lancet Neurol       Date:  2017-12-05       Impact factor: 44.182

4.  Porcine xenografts in Parkinson's disease and Huntington's disease patients: preliminary results.

Authors:  J S Fink; J M Schumacher; S L Ellias; E P Palmer; M Saint-Hilaire; K Shannon; R Penn; P Starr; C VanHorne; H S Kott; P K Dempsey; A J Fischman; R Raineri; C Manhart; J Dinsmore; O Isacson
Journal:  Cell Transplant       Date:  2000 Mar-Apr       Impact factor: 4.064

5.  Mesenchymal Stem Cells Inhibit Transmission of α-Synuclein by Modulating Clathrin-Mediated Endocytosis in a Parkinsonian Model.

Authors:  Se Hee Oh; Ha Na Kim; Hyun Jung Park; Jin Young Shin; Eun-Jin Bae; Mun Kyung Sunwoo; Seung-Jae Lee; Phil Hyu Lee
Journal:  Cell Rep       Date:  2016-01-14       Impact factor: 9.423

6.  Autotransplantation of human carotid body cell aggregates for treatment of Parkinson's disease.

Authors:  Ventura Arjona; Adolfo Mínguez-Castellanos; Rafael J Montoro; Angel Ortega; Francisco Escamilla; Juan José Toledo-Aral; Ricardo Pardal; Simón Méndez-Ferrer; José M Martín; Miguel Pérez; Majed J Katati; Eduardo Valencia; Teresa García; José López-Barneo
Journal:  Neurosurgery       Date:  2003-08       Impact factor: 4.654

Review 7.  Diagnosis and Treatment of Parkinson Disease: A Review.

Authors:  Melissa J Armstrong; Michael S Okun
Journal:  JAMA       Date:  2020-02-11       Impact factor: 56.272

8.  Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years.

Authors:  Ivar Mendez; Angel Viñuela; Arnar Astradsson; Karim Mukhida; Penelope Hallett; Harold Robertson; Travis Tierney; Renn Holness; Alain Dagher; John Q Trojanowski; Ole Isacson
Journal:  Nat Med       Date:  2008-04-06       Impact factor: 53.440

Review 9.  Stem cell therapy for Parkinson's disease: safety and modeling.

Authors:  Theo Stoddard-Bennett; Renee Reijo Pera
Journal:  Neural Regen Res       Date:  2020-01       Impact factor: 5.135

Review 10.  Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review.

Authors:  Klaus Seppi; K Ray Chaudhuri; Miguel Coelho; Susan H Fox; Regina Katzenschlager; Santiago Perez Lloret; Daniel Weintraub; Cristina Sampaio
Journal:  Mov Disord       Date:  2019-01-17       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.